-
Development of a human primary gut-on-a-chip to model inflammatory processes2020 Scientific Reports article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Claudia Beaurivage, Austė Kanapeckaitė, Cindy J.M. Loomans, Kai S. Erdmann, Jan Stallen, Richard A. J. Janssen
175citations -
Integrated safety analysis of filgotinib in patients with moderately to severely active rheumatoid arthritis receiving treatment over a median of 1.6 years2021 Annals of the Rheumatic Diseases article Medicine Rheumatoid Arthritis Research and Therapies Open access
Kevin L. Winthrop, Yoshiya Tanaka, Tsutomu Takeuchi, Alan Kivitz, Franziska G. Matzkies, Mark C. Genovese, +7 more
81citations -
Effects of filgotinib on semen parameters and sex hormones in male patients with inflammatory diseases: results from the phase 2, randomised, double-blind, placebo-controlled MANTA and MANTA-RAy studies
Walter Reinisch, Wayne J.G. Hellstrom, Radboud J. E. M. Dolhain, Suresh C. Sikka, René Westhovens, Rajiv M Mehta, +13 more
45citations -
Declining Enrolment and Other Challenges in IBD Clinical Trials: Causes and Potential Solutions2023 Journal of Crohn s and Colitis article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease
Mathieu Uzzan, Yoram Bouhnik, Maria Teresa Abreu, Shashi Adsul, Hilde Carlier, Marla Dubinsky, +13 more
38citations -
Opportunistic infections associated with Janus kinase inhibitor treatment for rheumatoid arthritis: A structured literature review2022 Seminars in Arthritis and Rheumatism article Medicine Rheumatoid Arthritis Research and Therapies Open access
Kevin L. Winthrop, John Dudley Isaacs, Leonard H. Calabrese, Deepali Mittal, Jane Barry, Sander Strengholt, +1 more
35citations -
Rapid and Sustained Symptom Relief in Patients With Ulcerative Colitis Treated With Filgotinib: Data From the Phase 2b/3 SELECTION Trial2022 The American Journal of Gastroenterology article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access cited by 1 patent
Silvio Danese, Marc Ferrante, Brian G. Feagan, Laurent Peyrin‐Biroulet, Toshifumi Hibi∥, William J. Sandborn, +10 more
31citations -
Optimization of a GnRHa treatment for spawning commercially reared greater amberjack Seriola dumerili: Dose response and extent of the reproductive season2020 Aquaculture article Biochemistry, Genetics and Molecular Biology Reproductive biology and impacts on aquatic species
Ioannis Fakriadis, Andrea Miccoli, Stelios Karapanagiotis, Nikoleta Tsele, Constantinos C. Mylonas
25citations -
Integrated safety analysis of filgotinib for ulcerative colitis: Results from SELECTION and SELECTIONLTE2023 Alimentary Pharmacology & Therapeutics article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Stefan Schreiber, Gerhard Rogler, Mamoru Watanabe, Severine A.R.A. Vermeire, Christian Maaser, Silvio Danese, +8 more
22citations -
A 3D Renal Proximal Tubule on Chip Model Phenocopies Lowe Syndrome and Dent II Disease Tubulopathy2021 International Journal of Molecular Sciences article Engineering 3D Printing in Biomedical Research Open access
Sindhu Naik, Andrew R. Wood, Maté Ongenaert, Paniz Saidiyan, Edo Elstak, Henriëtte L. Lanz, +4 more
20citations -
Filgotinib Improved Health-Related Quality of Life and Led to Comprehensive Disease Control in Individuals with Ulcerative Colitis: Data from the SELECTION Trial2023 Journal of Crohn s and Colitis article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Stefan Schreiber, Brian G. Feagan, Laurent Peyrin‐Biroulet, Severine A.R.A. Vermeire, Margaux Faes, Alessandra Faria Oortwijn, +3 more
18citations -
Residual Disease Burden Among European Patients With Inflammatory Bowel Disease: A Real-World Survey2024 Inflammatory Bowel Diseases article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Johan M. Burisch, Ailsa L Hart, Andreas Sturm, Christine Rudolph, Rachael Meadows, Anna Jus, +3 more
16citations -
Efficacy and safety of filgotinib as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a post-hoc analysis of the phase 2b/3 SELECTION trial2022 Intestinal Research article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Toshifumi Hibi∥, Satoshi Motoya, Tadakazu Hisamatsu, Fumihito Hirai, Kenji Watanabe, Katsuyoshi Matsuoka, +10 more
15citations -
Long‐term safety and efficacy of filgotinib for the treatment of moderately to severely active ulcerative colitis: Interim analysis from up to 4 years of follow‐up in the SELECTION open‐label long‐term extension study2024 Alimentary Pharmacology & Therapeutics article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Brian G. Feagan, Katsuyoshi Matsuoka, Gerhard Rogler, David Laharie, Severine A.R.A. Vermeire, Silvio Danese, +9 more
14citations -
THU0202 INTEGRATED SAFETY ANALYSIS OF FILGOTINIB TREATMENT FOR RHEUMATOID ARTHRITIS FROM 7 CLINICAL TRIALS2020 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
Mark C. Genovese, Kevin L. Winthrop, Yoshiya Tanaka, Tsutomu Takeuchi, Alan Kivitz, Franziska G. Matzkies, +7 more
13citations -
Corticosteroid-Sparing Effects of Filgotinib in Moderately to Severely Active Ulcerative Colitis: Data from the Phase 2b/3 SELECTION Study2022 Journal of Crohn s and Colitis article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Edward V. Loftus, Severine A.R.A. Vermeire, Brian G. Feagan, Franck‐Olivier Le Brun, Alessandra Faria Oortwijn, Ulrik Moerch, +2 more
12citations